[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336142-105":59,"doc-detail-336142-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pan-cancer-analysis-of-the-prognostic-and-immunological-role-of-fkbp4-research-article","Pan-cancer analysis of the prognostic and immunological role of FKBP4 - Research article","","Pan-cancer bioinformatics analysis investigates FK506-binding protein 4 (FKBP4) in tumorigenesis by characterizing expression patterns and evaluating its prognostic and immunological relevance. RNA sequencing, somatic mutation, and clinical records from TCGA are integrated with TISIDB, UALCAN, cBioPortal, CellMiner, and additional tools to assess survival outcomes, methylation links, molecular networks, immune infiltration features, and immunogenic biomarkers. FKBP4 is upregulated, associated with worse survival, and correlates with immune checkpoints, TMB/MMR/MSI, and multiple drug sensitivities.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-analysis-of-the-prognostic-and-immunological-role-of-fkbp4-research-article/336142/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-of-the-prognostic-and-immunological-role-of-fkbp4-research-article/336142.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main objective regarding FKBP4?","Question",{"text":112,"@type":113},"To determine FKBP4’s expression profile across cancers and evaluate its prognostic value and immunological associations in a pan-cancer framework.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which data sources and analytical tools are used?",{"text":117,"@type":113},"RNA-seq, somatic mutation, and clinical data from TCGA are analyzed with UCSC Xena and TISIDB, while methylation, network, copy-number mutations, functional enrichment, and immune-related features are assessed using UALCAN, cBioPortal, GO/clusterProfiler, TIMER and related resources.",{"name":119,"@type":110,"acceptedAnswer":120},"What are the key findings about FKBP4 and cancer outcomes?",{"text":121,"@type":113},"FKBP4 expression is significantly upregulated in multiple cancers; higher FKBP4 levels correlate with poorer OS, DSS, DFS, and PFS, and FKBP4 is linked to immune infiltrates, immune checkpoints, TMB, MMR, MSI, and several drug sensitivities.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336142,1790668607,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Heliyon 10 (2024) e29098  \nContents lists available at ScienceDirect  \nHeliyon  \njournal [homepage:](homepage: www.cell.com/heliyon)[ www.cell.com/heliyon](homepage: www.cell.com/heliyon)  \n| Research article\u003Cbr>Pan-cancer analysis of the prognostic and immunological role of FKBP4\u003Cbr>Hanchu Xiong b, 1, Zihan Chenc, 1, Yucheng Lib, 1, Zhuazhua Wu b, Da Qiand, Long Chen b, Qiang Lib, Huaxin Liu b, Weijun Chen b, Baihua Lin b, Yongshi Jiab, Cheng Wang a, *\u003Cbr>a Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China\u003Cbr>b Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China\u003Cbr>c Surgical Intensive Care Unit, First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, 310016, China\u003Cbr>d Department of Burn and Plastic Surgery-Hand Surgery, The Changshu Hospital Affiliated to Soochow University, Changshu, Jiangsu, 215000, China |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords: FKBP4\u003Cbr>Prognosis Immunology Pan-cancer Bioinformatics Methylation TMB\u003Cbr>MMR\u003Cbr>MSI |  | Objectives: Our previous studies revealed the significant roles of FK506-binding protein 4 (FKBP4) in tumorigenesis, however, there has been no pan-cancer analysis ofFKBP4. Using bioinformatics, the current study reported the expression and prognostic role of FKBP4, and the correlation between FKBP4 and clinicopathological parameters, methylation, molecular network, immunological traits and drug sensitivity.\u003Cbr>Methods: RNA sequencing data, somatic mutation, and related clinical information were obtained from TCGA using UCSC Xena. The association between FKBP4 expression and clinical features was assessed using TISIDB. The relationships between FKBP4 expression and tumour stage, OS, DSS, DFS, and PFS were analysed using univariate cox regression analysis. The radar plots for TMB and MSI were obtained using “Fmsb” R package. UALCAN was used to explore the effect of FKBP4 methylation on tumour and normal samples. CBioportal was used to analyse copy number mutations in FKBP4 Gene expression and drug sensitivity data were downloaded from the CellMiner database. GO analysis was performed for the high and the low expression of FKBP4 compared with the median level of FKBP4 using clusterProfiler4.0.\u003Cbr>Results: FKBP4 expression is significantly upregulated in various types of cancers. Cox regression analysis showed that high FKBP4 levels were correlated with poor OS, DSS, DFS, and PFS in most patients with cancer. Methylation of FKBP4 DNA was upregulated in most cancers, and FKBP4 expression is positively associated with transmethylase expression. FKBP4 and its copy were significantly associated with the expression of immune-infiltrating cells, immune checkpoint genes, immune modulators, TMB, MMR, and MSI. FKBP4 expression levels significantly correlated with 16 different drug sensitivities (all p \u003C 0.05).\u003Cbr>Conclusions: Our pan-cancer bioinformatic analysis revealed a potential mechanism underlying the effects of FKBP4 on the prognosis and progression of various cancers. |\n\n* Corresponding author.  \nE-mail address: [13777851323@163.com](13777851323@163.com) (C. Wang).  \n1 These authors contributed equally.  \n[https://doi.org/10.1016/j.heliyon.2024.e29098](https://doi.org/10.1016/j.heliyon.2024.e29098)  \nReceived 19 October 2023; Received in revised form 29 March 2024; Accepted 31 March 2024 Available online 2 April 2024  \n2405-8440/© 2024 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license  \n([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \n1. Introduction  \nCancer is an important cause of death globally. With a rising number of newly diagnosed cases [1], the economic burden of cancer continue","cbCaiqFhch9xuhfJ","https://ap.wps.com/l/cbCaiqFhch9xuhfJ","pdf",17776350,15,"English","# Objectives\n# Methods\n# Results\n# Conclusions\n# Introduction","[{\"question\":\"What is the study’s main objective regarding FKBP4?\",\"answer\":\"To determine FKBP4’s expression profile across cancers and evaluate its prognostic value and immunological associations in a pan-cancer framework.\"},{\"question\":\"Which data sources and analytical tools are used?\",\"answer\":\"RNA-seq, somatic mutation, and clinical data from TCGA are analyzed with UCSC Xena and TISIDB, while methylation, network, copy-number mutations, functional enrichment, and immune-related features are assessed using UALCAN, cBioPortal, GO/clusterProfiler, TIMER and related resources.\"},{\"question\":\"What are the key findings about FKBP4 and cancer outcomes?\",\"answer\":\"FKBP4 expression is significantly upregulated in multiple cancers; higher FKBP4 levels correlate with poorer OS, DSS, DFS, and PFS, and FKBP4 is linked to immune infiltrates, immune checkpoints, TMB, MMR, MSI, and several drug sensitivities.\"}]","Pan-cancer analysis of the prognostic and immunological role of FKBP4 - Research article | PDF",1790013790,38]